🔎 Trials Near Me

Beranda › Kanker Paru Non-Sel Kecil › California › Newport Beach

Uji klinis Kanker Paru Non-Sel Kecil di Newport Beach, CA

14 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Newport Beach (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Menerima pesertaFase 3
  • Hoag Hospital Newport Beach, Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06765109

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Menerima pesertaFase 1
  • Research Site, Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05877599

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Menerima pesertaFase 3
  • Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06312137

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Menerima pesertaFase 1
  • Research Site, Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06218914

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Menerima pesertaStudi observasional
  • Hoag Memorial Hospital Presbyterian, Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444

A Study of KK2269 in Adult Participants With Solid Tumors

Menerima pesertaFase 1
  • Hoag Memorial Hospital Presbyterian, Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06266299

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Menerima pesertaFase 1
  • Hoag Family Cancer Institute, Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06774963

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Menerima pesertaFase 3
  • Hoag Memorial Hospital Presbyterian, Newport Beach
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05317858

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • Hoag Memorial Hospital Presbyterian, Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04895709

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Menerima pesertaFase 1/2
  • Hoag Memorial Hospital Presbyterian, Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT05098132

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Menerima pesertaFase 3
  • Hoag Family Cancer Institute - Hoag Memorial Hospital, Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT06216301

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

Menerima pesertaFase 2
  • City of Hope at Newport Beach Fashion Island, Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT07288034

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1
  • Hoag Memorial Hospital Presbyterian, Newport Beach
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT05948865

Uji klinis Kanker Paru Non-Sel Kecil di kota lain

Studi lain di Newport Beach

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.